Overview

With the recent release of evidence-based ADHD guidelines, in addition to heightened public awareness, more people are seeking assessment for ADHD.

This two-part webinar aims to equip psychologists with the foundations to recognise and provide interventions to Attention Deficit Hyperactivity Disorder (ADHD) in adults.

It will cover:

• diagnostic assessments,

• case conceptualisation to inform intervention planning, and

• effective psychological intervention.

Webinar 1: Tuesday 23 July 2024, 9.30am-1:30pm AEST

• neurobiology and cognitive profile of ADHD,

• model for understanding the experience of ADHD,

• signs and symptoms of ADHD across the lifespan – looking beyond DSM-5 criteria,

• common differential and co-occurring conditions,

• evidence-based diagnostic assessment,

• framework for a comprehensive assessment process,

• assessment troubleshooting - data accessibility, validity concerns, complex presentations,

• impact of ADHD symptoms on assessment process,

• providing and reporting assessment outcomes, and

• ethical considerations during assessment phase – stigma, socio-political context, and neurodivergence-affirming practice. 

Webinar 2: Wednesday, 24 July 2024, 9.30am-1:30pm AEST

• case conceptualisation and intervention planning,

• evidence-based intervention for primary and secondary impacts of ADHD,

• practical application of evidence-base, and

• monitoring for and addressing barriers to progress - stigma, grief/acceptance, motivation for change, expectations, influences of important others, and impacts. 

Prerequisite

Participants will be required to view a 1 hour recording in preparation for this activity. The recording is included as part of the enrolment fee and will be provided to participants prior to the webinar.

Level of Learning

Foundational. This activity is targeted to those new to the topic.

Duration of access

These webinars will be recorded and made available only to participants of the live event for 12 months. The recording is not intended to replace live participation.

Places are limited and registration will not be available after the webinar has taken place.

APS CPD-Approved

This activity has been assessed against the APS Standards for CPD activities and approved for its education quality. Learn more about the APS CPD Approval process.

CPD Frequently Asked Questions

Refer to the APS CPD Frequently Asked Questions for general and technical information when undertaking APS Professional development activities.

Learning Outcomes

Upon completion of these webinars, participants should be able to:

• use a model of ADHD to understand the cognitive experience of ADHD,

• use neuro-divergent affirming language to discuss those experiences with individuals with ADHD,

• recognise common secondary outcomes from ADHD as they present across the lifespan,

• describe a framework that will guide a comprehensive diagnostic assessment for ADHD in adults,

• conduct a case conceptualisation for intervention planning wit an adult diagnosed with ADHD,

• recognise how psychologists can implement the components of evidence-based non-pharmacological treatment for ADHD (as outlined in the Australian Evidence-based Clinical Guidelines for ADHD, 2022), and

• address challenges that may arise in the provision of ADHD intervention to adults.

Presenter(s)

Dr Maddi Derrick MAPS

About the presenter(s)

Dr Maddi Derrick is the founding director of Hobart ADHD Consultants, where she leads a team of psychologists providing neurodivergent-affirming assessment and treatment services for ADHD and co-occurring conditions.
As a Clinical Psychologist she works predominantly with adults with ADHD and parents of children with ADHD, and provides training and supervision for her team who work with individuals of all ages. She also provides cross-discipline training to external agencies.
With lived experience of ADHD, Maddi is a passionate advocate for systemic change. She has been a very active member of the Australian ADHD Professionals Association, including being a member of the guideline development group for the ‘Australian Evidence-based Clinical Guidelines for ADHD’ (2022). She also assists with research projects and advocacy initiatives, and is a regular contributor to media around ADHD.